Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up Women only

Dexmedetomidine or Clonidine added to spinal anesthesia for cesarean delivery

Official title: Adding Dexmedetomidine or Clonidine to Spinal Anesthesia for Cesarean Delivery

Run by Columbia University · NCT07567495 · Data updated 2026-11-12

This study tests whether adding dexmedetomidine or clonidine to spinal anesthesia for cesarean delivery improves intraoperative comfort and analgesia.

More Dexmedetomidine trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment150 (estimated)
SponsorColumbia University
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedMay 14, 2026
Main results expectedMay 14, 2028
Study endsMay 15, 2028
Registry record updatedOctober 29, 2026
Trial IDNCT07567495 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Pregnant women undergoing cesarean delivery with spinal anesthesia who meet inclusion criteria and none of the exclusion criteria.

Probably not a fit

Patients with contraindications to alpha-2 agonists or those who do not respond to adjuvants may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In cesarean deliveries, spinal anesthesia with bupivacaine and opioids is standard but some patients feel pulling or pressure during the procedure. The trial compares two alpha-2 adrenergic drugs, dexmedetomidine and clonidine, as intrathecal adjuvants to see if they reduce uncomfortable sensations and extend the duration of the block. It is an interventional, phase 4 study conducted at Columbia University focusing on women undergoing cesarean delivery with spinal anesthesia. Outcomes likely include intraoperative comfort, block duration, and postoperative pain, with safety monitoring for known drug effects. Enrollment is limited to eligible pregnant women without major comorbidities or restrictions listed in the criteria.

Why it matters

Potential benefit: If successful, this approach could improve intraoperative comfort and extend analgesia for cesarean patients.

How similar studies have gone: Prior studies have explored intrathecal alpha-2 agonists as adjuvants with mixed but generally supportive evidence for improved analgesia and block duration.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pregnant women undergoing cesarean delivery with spinal anesthesia

Exclusion Criteria:

* Significant cardiovascular, psychiatric or respiratory disease
* using opioids or with chronic pain syndrome
* Multiple gestation
* BMI \>40 kg/m2
* Quaternary or greater cesarean
* \< 37 weeks gestation
* Non-English or Spanish speaking
* planned vertical skin incision
* planned vertical (classical) uterine incision
* allergy to clonidine, dexmedetomidine or other study drug

Where it's running

  • Columbia University Irving Medical Center/NewYork Presbyterian Hospital
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.